Ftse Mib
33.645,43
-0,27%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
62.957,09
6,49%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ CorMedix Inc (CRMD) CorMedix Inc (CRMD) Notizie

CorMedix Inc

CRMD
5,84
0,47 (8,75%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:40:07
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/4/202414:30GLOBECorMedix Inc. Announces CMS Grants TDAPA to DefenCath
15/4/202414:30GLOBECorMedix Inc. Announces U.S. Inpatient Commercial..
12/3/202412:30GLOBECorMedix Inc. Reports Fourth Quarter and Full Year 2023..
30/1/202423:26EDGAR2Form 8-K - Current report
18/1/202422:53EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
18/1/202402:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202402:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202402:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202402:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202314:39EDGAR2Form 8-K - Current report
14/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202322:11EDGAR2Form 8-K - Current report
14/11/202322:05GLOBECorMedix Inc. Reports Third Quarter and Nine Month 2023..
30/10/202321:35EDGAR2Form 8-K - Current report
11/10/202314:30GLOBECorMedix Inc. Announces Abstract Presentation at Upcoming..
13/9/202323:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
13/9/202323:20EDGAR2Form DEF 14A - Other definitive proxy statements
08/9/202322:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202314:30GLOBECorMedix Inc. Announces Publication of Phase 3 LOCK IT-100..
30/8/202314:00GLOBECorMedix Inc. Announces Issuance of U.S. Patent Covering..
17/8/202314:30EDGAR2Form 8-K - Current report
08/8/202314:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202313:45EDGAR2Form 8-K - Current report
08/8/202313:30GLOBECorMedix Inc. Reports Second Quarter and Six Month 2023..
30/6/202322:40EDGAR2Form 8-K - Current report
30/6/202322:38EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/6/202304:57GLOBECorMedix Inc. Announces Pricing of $40 Million Public..
28/6/202323:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/6/202322:07GLOBECorMedix Inc. Announces Proposed Public Offering of Common..
21/6/202314:30GLOBECorMedix Inc. Announces FDA Acceptance of Resubmission of..
15/6/202314:30GLOBECormedix Inc. Announces Strategic Initiative With Boston..
16/5/202313:00GLOBECorMedix Inc. Announces Resubmission of New Drug Application..
15/5/202322:05GLOBECorMedix Inc. Reports First Quarter 2023 Financial Results..
Apertura: 5,49 Min: 5,4305 Max: 5,92
Chiusura: 5,37

La tua Cronologia

NASDAQ
CRMD
CorMedix
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network